Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medical Matters International is a global medical communications agency that provides strategic and tactical support to the pharmaceutical, biotechnology, and healthcare industries. As a division of Nucleus Global, the company specializes in medical writing, scientific storytelling, publication planning, and the development of continuing medical education (CME) programs. MMI focuses on bridging the gap between clinical research and clinical practice by delivering high-quality educational content and engagement strategies for healthcare professionals. Their expertise spans a wide range of therapeutic areas, including oncology, cardiovascular health, and rare diseases. Following the merger of Ashfield and Huntsworth, MMI operates as part of the Inizio group, one of the world's largest healthcare services providers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medical Matters International.